Structural valve deterioration in the Mitroflow biological heart valve prosthesis

Back

ESC Premium Access

Structural valve deterioration in the Mitroflow biological heart valve prosthesis

Session: Poster session 7 - Biomarkers and phenotype in aortic stenosis

Topic: Aortic valve disease

Speaker: Doctor I. Issa (Odense, DK)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Issa Farah Issa

Odense University Hospital, Odense (Denmark)

0 follower

13 more presentations in this session

Prognostic impact of B-type natriuretic peptide after transcatheter aortic valve replacement in patients with severe aortic stenosis

Speaker: Doctor K. Sato (Tsukuba, JP)

Access

Abstract

Slides

Cystatin C and neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of TAVI associated acute kidney injury

Speaker: Doctor L. Gaede (Erlangen, DE)

Access

Abstract

Slides

Plasma ACE2 activity is a novel and independent predictor of all-cause mortality in patients with aortic stenosis.

Speaker: Doctor J. Ramchand (Cleveland, US)

Access

Abstract

Slides

Apolipoprotein E and Paraoxonase 1 serum concentration and genetic polymorphism in aortic valve calcification

Speaker: Professor O. Boeva (Stavropol, RU)

Access

Slides

RANKL expression is increased in peripheral mononuclear cells of patients with severe aortic valve stenosis and promotes pro-calcific differentiation of valve cells

Speaker: Doctor R. Buso (Treviso, IT)

Access

Abstract

Slides

Access the full session

Poster session 7 - Biomarkers and phenotype in aortic stenosis

Speakers: Doctor I. Issa, Doctor K. Sato, Doctor L. Gaede, Doctor J. Ramchand, Professor O. Boeva...

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources